Avicanna Raises $3.2M Via Non-Brokered Offering, Announces Warrant Repricing
Cannabis-focused biopharmaceutical company Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) confirmed Tuesday that it had closed a non-brokered private placement raising CA$3.9 million ($3.16 million). Under the offering, the company
